Appeals Court Holds US Humira Patents Invalid

Upholds 2017 Inter Partes Review Decisions On Three Patents

 
• By David Wallace
  
Denied_Stamp
AbbVie’s appeal over the Humira patents was denied • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin